# A Study to Assess the Safety of MEB-1170 in Healthy Subjects

> **NCT05748119** · PHASE1 · UNKNOWN · sponsor: **Mebias Discovery, Inc** · enrollment: 72 (estimated)

## Conditions studied

- Pain

## Interventions

- **DRUG:** MEB-1170
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05748119
- **Lead sponsor:** Mebias Discovery, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-15
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05748119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05748119, "A Study to Assess the Safety of MEB-1170 in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05748119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*